Results 41 to 50 of about 211 (73)

Sudden-onset dystonia in a patient taking asenapine: interaction between ciprofloxacin and asenapine metabolism. [PDF]

Am J Psychiatry, 2015
Ridout KK, Ridout SJ, Pirnie LF, Puttichanda SP.   +3 more
europepmc   +1 more source

Repurposing of lonafarnib as a treatment for SARS-CoV-2 infection. [PDF]

JCI Insight
Khan M, Irvin P, Park SB, Ivester HM, Ricardo-Lax I, Leek M, Grieshaber A, Jang ES, Coutermarsh-Ott S, Zhang Q, Maio N, Jiang JK, Li B, Huang W, Wang AQ, Xu X, Hu Z, Zheng W, Ye Y, Rouault T, Rice C, Allen IC, Liang TJ.   +22 more
europepmc   +1 more source

Safety assessment of asenapine in the FAERS database: real adverse event analysis and discussion on neurological and psychiatric side effects. [PDF]

BMC Pharmacol Toxicol
Jin L, Gu J, Wu Y, Xia H, Xie G, Zhu G.
europepmc   +1 more source

Lonafarnib Protects Against Muscle Atrophy Induced by Dexamethasone. [PDF]

J Cachexia Sarcopenia Muscle
Bae S, Mai VH, Mun S, Dong D, Han K, Park S, Hyun JK.   +6 more
europepmc   +1 more source

The Effects of Antipsychotics on the Synaptic Plasticity Gene Homer1a Depend on a Combination of Their Receptor Profile, Dose, Duration of Treatment, and Brain Regions Targeted. [PDF]

Int J Mol Sci, 2020
Iasevoli F, Buonaguro EF, Avagliano C, Barone A, Eramo A, Vellucci L, de Bartolomeis A.   +6 more
europepmc   +1 more source

Genetic and pharmacological modulation of lamin A farnesylation determines its function and turnover. [PDF]

Aging Cell
Foo MXR, Ong PF, Yap ZX, Maric M, Bong CJS, Dröge P, Burke B, Dreesen O.   +7 more
europepmc   +1 more source

Intracellular Doppler Spectroscopy detects altered drug response in SKOV3 tumor spheroids with silenced or inhibited P-glycoprotein. [PDF]

Biochem Biophys Res Commun, 2019
Narayanan G, Merrill D, An R, Nolte DD, Turek JJ.   +4 more
europepmc   +1 more source

Early improvements of individual symptoms as a predictor of treatment response to asenapine in patients with schizophrenia. [PDF]

Neuropsychopharmacol Rep, 2020
Ogyu K, Noda Y, Yoshida K, Kurose S, Masuda F, Mimura Y, Nishida H, Plitman E, Tarumi R, Tsugawa S, Wada M, Miyazaki T, Uchida H, Graff-Guerrero A, Mimura M, Nakajima S.   +15 more
europepmc   +1 more source

Structural insight into substrate and inhibitor discrimination by human P-glycoprotein. [PDF]

Science, 2019
Alam A, Kowal J, Broude E, Roninson I, Locher KP.   +4 more
europepmc   +1 more source

New Agents in the Treatment of Psychiatric Disorders: What Innovations and in What Areas of Psychopathology? [PDF]

Pharmaceuticals (Basel)
Bozzatello P, Novelli R, Schisano R, Brasso C, Rocca P, Bellino S.   +5 more
europepmc   +1 more source